$Histogenics(OCGN)$ good dip to buy. Covaxin effective against 3 new mutated variant including india's double mutant. EUA and FDA on the way, once approved we will be positioned near Moderna's market cap if not Novavax. Easy storage, charging 10bucks per vax, 40% net profit deal partnership w India. Imagine the possibilities. This Friday is the day
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
5
举报
登录后可参与评论
- 马达娃娃·2021-05-04看好ocgn吗点赞举报